Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07165808 · ClinicalTrials.gov registry record · NA
Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches
A NA study of Nicotine Addiction, sponsored by Emory University.
- Recruiting
- Registry status
- NA
- Development phase
- 84
- Enrollment target
- 1
- Study location
NCT07165808: Recruiting NA study of Nicotine Addiction, sponsored by Emory University.
NCT07165808 is a NA study of Nicotine Addiction that is actively recruiting participants, run by Emory University. The registered enrollment target is 84 participants, below the 716-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (88% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07165808, a NA study of Nicotine Addiction, is actively recruiting participants, sponsored by Emory University.
- RECRUITING
- Registry status
- NA
- Development phase
- 84 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to assess the effects of nicotine concentration and its interplay with pH on sensory experience, product appeal, and abuse liability of NPs among young adults NP users. Primary objective is to assess the effect of variation in nicotine concentration in nicotine pouches (NPs) and its interaction effect with pH level on three proximal outcomes of relevance to regulation: (1) sensory experience, (2) product appeal, and (3) abuse liability of NPs.
Primary Outcome
Total amount of time with Nicotine Pouches in mouth (excluding periods in between NPs after disposal)
Conditions Studied
Interventions
- OTHER Nicotine pouch: Low dose
- OTHER Nicotine pouch: High dose
- OTHER Low pH
- OTHER High pH
Study Locations (1)
Georgia
- Rollins School of Public Health - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 84 participants |
| Start Date | 2026-02-13 |
| Est. Completion | 2028-01 |
| Phase | NA |
What NCT07165808 shows while recruiting
NCT07165808 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 84 participants, a relatively small participant target, below the 716-participant average among 10 other Nicotine Addiction trials with a reported enrollment target (88% lower).
The record links to 1 condition, with Nicotine Addiction appearing as the primary indexed condition, and to 4 interventions - of which Nicotine pouch: Low dose is the first listed.
NCT07165808 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT07165808 about?
NCT07165808 is a clinical study titled "Effect of Product Characteristics on the Abuse Liability of Nicotine Pouches". The goal of this study is to assess the effects of nicotine concentration and its interplay with pH on sensory experience, product appeal, and abuse liability of NPs among young adults NP users. Primary objective is to assess the effect of variation in nicotine concentration in nicotine pouches (NP...
What is the current status of trial NCT07165808?
This trial is currently recruiting. It is a NA study. The enrollment target is 84 participants. The study started on 2026-02-13. Estimated completion is 2028-01.
What conditions does trial NCT07165808 study?
This clinical trial studies the following conditions: Nicotine Addiction.
What interventions are being tested in trial NCT07165808?
The interventions under investigation include: Nicotine pouch: Low dose (OTHER), Nicotine pouch: High dose (OTHER), Low pH (OTHER), High pH (OTHER).
Who is sponsoring clinical trial NCT07165808?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07165808 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Nicotine Addiction
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT07165808's enrollment target sits among peer trials
84 8th of 10 higher than 3 of 10 other Nicotine Addiction trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Nicotine Addiction trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
CONNECT Cancer Survivors With Tobacco Treatment
RECRUITING · NA
-
Circuitry-Guided Smoking Cessation in Schizophrenia (UH3)
RECRUITING · NA
-
Cognitive Training for Nicotine Dependence
COMPLETED · NA
-
Effects of Brief Training on Craving Regulation
COMPLETED · NA
-
Acute and Chronic Nicotine Modulation of Reinforcement Learning
COMPLETED · NA
-
Computer-Facilitated 5A's for Smoking Cessation in Primary Care
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02391519 · 84 participants
Effects of High Altitude on AMPK Activation
- NCT03838536 · 84 participants · NA
Synergistic Activity of Human Milk Nutrients and Infant Cognition
- NCT03884075 · 84 participants · Phase 2
Non-Alcoholic Fatty Liver Disease, the HEpatic Response to Oral Glucose, and the Effect of Semaglutide (NAFLD HEROES)
- NCT03894917 · 84 participants
Characterizing Disease Biology, Treatment and Toxicity in Older Adults With Hepatocellular Carcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI